MYUNGMOON Pharm co.,Ltd

KSE 017180.KS

MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2023: USD 24.13 M

MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities is USD 24.13 M for the year ending December 31, 2023, a 25.39% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2022 was USD 19.25 M, a -5.39% change year over year.
  • MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2021 was USD 20.34 M, a -17.72% change year over year.
  • MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2020 was USD 24.72 M, a -43.61% change year over year.
  • MYUNGMOON Pharm co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2019 was USD 43.84 M, a 84.05% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
KSE: 017180.KS

MYUNGMOON Pharm co.,Ltd

Description

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.

Similar companies

003060.KS

Aprogen pharmaceuticals,Inc.

USD 0.50

-4.09%

019170.KS

Shin Poong Pharm.Co.,Ltd.

USD 6.88

-1.99%

003850.KS

Boryung Corporation

USD 6.82

-1.91%

016580.KS

Whan In Pharm Co.,Ltd.

USD 7.90

-1.67%

StockViz Staff

February 4, 2025

Any question? Send us an email